More than 230,000 men in the United States will be diagnosed with prostate cancer this year; that is about one in six men. It is the second leading cause of death from cancer in men. Screening for prostate cancer includes a prostate-specific antigen (PSA) blood test combined with a digital rectal exam (DRE).
Recently, the American Urological Association (AUA) issued new guidelines for prostate cancer screening. Those that will benefit most from screenings are as follows:
- Men aged 40 to 54 who are at higher risk for prostate cancer (African-American men and men with a family history of prostate cancer)
- Men aged 55 to 69
- Men who are older than 70 who are in excellent health with a life expectancy of greater than 10 years
“With regular screening, prostate cancer can be diagnosed at an early stage. We know that not all men with prostate cancer require treatment, however, those with clinically significant issues should be treated to prevent early death or complications from the spread of the disease,” says Vincenzo Galati, DO, FACS, board certified urologist at Saint Francis Medical Center.